D. A. Arber, A. Orazi, R. Hasserjian, J. Thiele, M. J. Borowitz et al., The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood. 19 mai, vol.127, issue.20, pp.2391-405, 2016.

G. Simonneau, M. A. Gatzoulis, I. Adatia, D. Celermajer, C. Denton et al., Updated Clinical Classification of Pulmonary Hypertension, J Am Coll Cardiol. déc, vol.62, issue.25, pp.34-41, 2013.

N. Galiè, M. Humbert, J. Vachiery, S. Gibbs, I. Lang et al., ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Heart J. 1 janv, vol.37, issue.1, pp.67-119, 2015.

L. G. Rudski, Point: Can Doppler Echocardiography Estimates of Pulmonary Artery Systolic Pressures Be Relied Upon to Accurately Make the Diagnosis of Pulmonary Hypertension?, Yes. Chest. juin, vol.143, issue.6, pp.1533-1539, 2013.

P. G. Yock and R. L. Popp, Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation, vol.70, pp.657-62, 1984.

M. M. Hoeper, H. J. Bogaard, R. Condliffe, R. Frantz, D. Khanna et al., Definitions and Diagnosis of Pulmonary Hypertension, J Am Coll Cardiol. déc, vol.62, issue.25, pp.42-50, 2013.

D. 'alto, M. Bossone, E. Opotowsky, A. R. Ghio, S. Rudski et al., Strengths and weaknesses of echocardiography for the diagnosis of pulmonary hypertension, Int J Cardiol. juill, vol.263, pp.177-83, 2018.

S. Lafitte, X. Pillois, P. Reant, F. Picard, F. Arsac et al., Estimation of Pulmonary Pressures and Diagnosis of Pulmonary Hypertension by Doppler Echocardiography: A Retrospective Comparison of Routine Echocardiography and Invasive Hemodynamics, J Am Soc Echocardiogr. mai, vol.26, issue.5, pp.457-63, 2013.

D. Chemla, M. Humbert, O. Sitbon, D. Montani, and P. Hervé, Systolic and Mean Pulmonary Artery Pressures, Chest. avr, vol.147, issue.4, pp.943-50, 2015.

Y. Adir, D. Elia, and S. Harari, Pulmonary hypertension in patients with chronic myeloproliferative disorders, Eur Respir Rev. sept, vol.24, issue.137, pp.400-410, 2015.

R. Costello, Hypertension artérielle pulmonaire et hémopathies malignes, Rev Médecine Interne. sept, vol.31, issue.9, pp.621-626, 2010.

A. Cortelezzi, G. Gritti, D. Papa, N. Pasquini, M. C. Calori et al., Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status, Leukemia. mars, vol.22, issue.3, pp.646-655, 2008.

A. Altintas, Z. Karahan, S. Pasa, T. Cil, T. Boyraz et al., Pulmonary hypertension in patients with essential thrombocythemia and reactive thrombocytosis, Leuk Lymphoma. janv, vol.48, issue.10, pp.1981-1988, 2007.

R. Gupta, S. Perumandla, Y. Patsiornik, S. Niranjan, and A. Ohri, Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders, J Natl Med Assoc, vol.98, issue.11, pp.1779-82, 2006.

G. Kadikoylu, A. Onbasili, T. Tekten, S. Barutca, and Z. Bolaman, Functional and morphological cardiac changes in myeloproliferative disorders (clinical study), Int J Cardiol, vol.97, issue.2, pp.213-233, 2004.

V. Garypidou, S. Vakalopoulou, D. Dimitriadis, K. Tziomalos, G. Sfikas et al., Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders, Haematologica. 1 janv, vol.89, issue.2, pp.245-251, 2004.

S. Chebrek, K. Aïssi, Y. Francès, C. Mercier, L. Farnault et al., Pulmonary hypertension in patients with chronic myeloproliferative neoplasms, Leuk Lymphoma. janv, vol.55, issue.1, pp.223-228, 2014.

S. Greiner, J. A. Aurich, M. Hess, A. Hilbel, T. Hardt et al., Reliability of Noninvasive Assessment of Systolic Pulmonary Artery Pressure by Doppler Echocardiography Compared to Right Heart Catheterization: Analysis in a Large Patient Population, J Am Heart Assoc. 21 août, vol.3, issue.4, pp.1103-001103, 2014.

A. J. Peacock, N. F. Murphy, J. Mcmurray, L. Caballero, and S. Stewart, An epidemiological study of pulmonary arterial hypertension, Eur Respir J. 14 mars, vol.30, issue.1, pp.104-113, 2007.

M. M. Hoeper, D. Huscher, and D. Pittrow, Incidence and prevalence of pulmonary arterial hypertension in Germany, Int J Cardiol. janv, vol.203, pp.612-615, 2016.

P. Guilpain, D. Montani, G. Damaj, L. Achouh, F. Lefrère et al., Pulmonary Hypertension Associated with Myeloproliferative Disorders: A Retrospective Study of Ten Cases, Respiration, vol.76, issue.3, pp.295-302, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00356272

G. García-manero, S. J. Schuster, H. Patrick, and J. Martinez, Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases, Am J Hematol. févr, vol.60, issue.2, pp.130-135, 1999.

D. Dingli, J. P. Utz, M. J. Krowka, A. L. Oberg, and A. Tefferi, Unexplained pulmonary hypertension in chronic myeloproliferative disorders, Chest. sept, vol.120, issue.3, pp.801-809, 2001.

M. Schneider, A. M. Pistritto, C. Gerges, M. Gerges, C. Binder et al., Multi-view approach for the diagnosis of pulmonary hypertension using transthoracic echocardiography, Int J Cardiovasc Imaging, vol.11, issue.2017

. Disponible,

N. P. Shah, N. Wallis, H. W. Farber, M. J. Mauro, R. A. Wolf et al., Clinical features of pulmonary arterial hypertension in patients receiving dasatinib: Summary of PAH in Dasatinib-Treated Patients, Am J Hematol, vol.90, issue.11, pp.1060-1064, 2015.

W. Rasheed, B. Flaim, and J. F. Seymour, Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia, Leuk Res. juin, vol.33, issue.6, pp.861-865, 2009.

B. ,

, MPAL with t(v;11q23.3); KMT2A rearranged MPAL, B/myeloid, NOS

M. and T. Myeloid,

, B-lymphoblastic leukemia/lymphoma B-lymphoblastic leukemia/lymphoma, NOS

, B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities B-lymphoblastic leukemia/lymphoma with t

B. ,

, B-lymphoblastic leukemia/lymphoma with t(v;11q23.3);KMT2A rearranged B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1), pp.6-7

, B-lymphoblastic leukemia/lymphoma with hyperdiploidy B-lymphoblastic leukemia/lymphoma with hypodiploidy B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1 Provisional entity: B-lymphoblastic leukemia/lymphoma, BCR-ABL1-like Provisional entity

, leukemia/lymphoma Provisional entity: Early T-cell precursor lymphoblastic leukemia Provisional entity: Natural killer (NK) cell lymphoblastic leukemia/lymphoma